ESC Premium Access

Prior antithrombotic therapy: a snapshot of 17,769 patients from the global edoxaban treatment in routine clinical practice in patients with non-valvular atrial fibrillation programme (global ETNA-AF)

Congress Presentation

About the speaker

Professor Raffaele De Caterina

University of Pisa, Pisa (Italy)
37 presentations
2 followers

10 more presentations in this session

Antithrombotic management in patients with atrial fibrillation and acute coronary syndromes

Speaker: Associate Professor B. Hudzik (Zabrze, PL)

Thumbnail

Advantage of novel oral anticoagulants compared to vitamin-K antagonist in atrial fibrillation. Data from real world.

Speaker: Doctor G. Simonyi (Budapest, HU)

Thumbnail

Oral anticoagulation continuation vs. discontinuation after catheter-ablation of paroxysmal atrial fibrillation - incidence of cerebral insults and severe hemorrhagic complications

Speaker: Ms L. Pracht (Munich, DE)

Thumbnail

A new score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs

Speaker: Doctor O. Rutherford (Sarpsborg, NO)

Thumbnail

Difference of efficacy and safety of left atrial appendage closure using watchman between patients aged less than 75 to more than 75 years

Speaker: Doctor J. Yu (Lichtenfels, DE)

Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation - Stroke prevention 2

Speakers: Professor R. De Caterina, Associate Professor B. Hudzik, Doctor G. Simonyi, Ms L. Pracht, Doctor O. Rutherford...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations